CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/EBDB93C1.svg?ark=w1%2F20260526%2FEBDB93C1&value=id)](https://nobleid.org/work/w1/20260526/EBDB93C1)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors